Skip to main content
Equibles
ADPT logo

ADPT · Adaptive Biotechnologies Corp · Webcasts, Transcripts & Audio

Track ADPT — free

Use ADPT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ADPT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$28.35 +0.98 (+3.58%) At close · Oct 2
Russell 2000 member Rebalance outlook locked
Market Cap
$4.52B
Shares
159.60M
Volume · Oct 2 1.58M Avg daily vol (57 sessions) 2.41M

Adaptive Biotechnologies Corp Webcasts

Earnings calls, investor updates, investor days and conferences for Adaptive Biotechnologies Corp (ADPT), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲21.2% $47.83M −$45.28M '22 Q3 22-11-03 ▲45.5% $55.20M −$40.13M '22 Q4 23-02-14 ▼2.5% $37.65M −$57.70M '23 Q1 23-05-03 ▲12.1% $48.93M −$47.81M '23 Q2 23-08-02 ▼20.7% $37.92M −$50.30M '23 Q3 23-11-09 ▼17.1% $45.78M −$69.44M '23 Q4 24-02-14 ▲11.2% $41.87M −$47.51M '24 Q1 24-04-02 ▼11.7% $43.19M −$46.22M '24 Q2 24-08-01 ▲22.5% $46.44M −$32.07M '24 Q3 24-11-07 ▲3.7% $47.46M −$33.69M '24 Q4 25-02-11 ▲25.2% $52.44M −$29.85M '25 Q1 25-05-01 ▲36.3% $58.88M −$25.61M '25 Q2 25-08-05 ▲102.4% $93.97M $9.55M '25 Q3 25-11-05 ▲51% $71.68M −$13.58M '25 Q4 26-02-05 ▲35.1% $70.87M −$20.03M '26 Q1 26-05-05 LATEST ▲21.5% $71.55M −$39.79M '26 Q2 26-07-29
Earnings call
FY26 · Q2
2026-07-29
Adaptive Biotechnologies Corp (ADPT) Q2 2026 Earnings Call Transcript
Confident tone Immune medicine separation Clinical MRD volume growth MRD pricing and reimbursement
Revenue
$71.55M
▲ 21.5% YoY
Diluted EPS
$-0.25
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-03
Adaptive Biotechnologies Corp (ADPT) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
Adaptive Biotechnologies Corp (ADPT) Q1 2026 Earnings Call Transcript
Confident tone MRD revenue and volume growth Biopharma/pharma business and backlog EMR integration and workflows
Revenue
$70.87M
▲ 35.1% YoY
Diluted EPS
$-0.13
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-05
Adaptive Biotechnologies Corp (ADPT) Q4 2025 Earnings Call Transcript
Confident tone MRD business growth and profitability ClonoSEQ volume and test growth ASP expansion and payer contracts
Revenue
$71.68M*
▲ 51% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Adaptive Biotechnologies Corp (ADPT) Q3 2025 Earnings Call Transcript
Confident tone Guideline and reimbursement wins EMR integration and community expansion MRD Pharma and clinical trial demand
Revenue
$93.97M
▲ 102.4% YoY
Diluted EPS
$0.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Adaptive Biotechnologies Corp (ADPT) Q2 2025 Earnings Call Transcript
Confident tone MRD business growth and profitability EMR integration and community expansion MRD pharma backlog and clinical trials
Revenue
$58.88M
▲ 36.3% YoY
Diluted EPS
$-0.17
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings Call Transcript
Confident tone MRD/clonoSEQ clinical volume growth MRD Pharma business Full-year guidance raise
Revenue
$52.44M
▲ 25.2% YoY
Diluted EPS
$-0.20
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-11
Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Call Transcript
Confident tone MRD clinical testing growth Pricing and reimbursement (ASP) NeoGenomics commercial partnership
Revenue
$47.46M*
▲ 3.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Transcript
Confident tone MRD pharma partnerships and milestones MRD revenue growth and clonoSEQ test volume EMR integration (Epic, Flatiron)
Revenue
$46.44M
▲ 22.5% YoY
Diluted EPS
$-0.22
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
Adaptive Biotechnologies Corp (ADPT) Q2 2024 Earnings Call Transcript
Confident tone MRD clinical growth (clonoSEQ) MRD pharma momentum post-ODAC Immune medicine / autoimmune discovery
Revenue
$43.19M
▼ 11.7% YoY
Diluted EPS
$-0.31
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-02
Adaptive Biotechnologies Corp (ADPT) Q1 2024 Earnings Call Transcript
Confident tone MRD Business Growth ODAC and MRD as Endpoint Immune Medicine / Restructuring
Revenue
$41.87M
▲ 11.2% YoY
Diluted EPS
$-0.33
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-14
Adaptive Biotechnologies Corp (ADPT) Q4 2023 Earnings Call Transcript
Positive tone MRD / clonoSEQ growth Immune medicine / Genentech partnership ASP and revenue cycle improvement
Revenue
$45.78M*
▼ 17.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Adaptive Biotechnologies Corp (ADPT) Q3 2023 Earnings Call Transcript
Revenue
$37.92M
▼ 20.7% YoY
Diluted EPS
$-0.35
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
Adaptive Biotechnologies Corp (ADPT) Q2 2023 Earnings Call Transcript
Revenue
$48.93M
▲ 12.1% YoY
Diluted EPS
$-0.33
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
Adaptive Biotechnologies Corp (ADPT) Q1 2023 Earnings Call Transcript
Revenue
$37.65M
▼ 2.5% YoY
Diluted EPS
$-0.40
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-14
Adaptive Biotechnologies Corp (ADPT) Q4 2022 Earnings Call Transcript
Revenue
$55.20M*
▲ 45.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Adaptive Biotechnologies Corp (ADPT) Q3 2022 Earnings Call Transcript
Revenue
$47.83M
▲ 21.2% YoY
Diluted EPS
$-0.32
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
Adaptive Biotechnologies Corp (ADPT) Q2 2022 Earnings Call Transcript
Revenue
$43.66M
▲ 13.4% YoY
Diluted EPS
$-0.37
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
Adaptive Biotechnologies Corp (ADPT) Q1 2022 Earnings Call Transcript
Revenue
$38.62M
▲ 0.5% YoY
Diluted EPS
$-0.44
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-15
Adaptive Biotechnologies Corp (ADPT) Q4 2021 Earnings Call Transcript
Revenue
$37.93M*
▲ 25.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Adaptive Biotechnologies Corp (ADPT) Q3 2021 Earnings Call Transcript
Revenue
$39.47M
▲ 50.1% YoY
Diluted EPS
$-0.40
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Adaptive Biotechnologies Corp (ADPT) Q2 2021 Earnings Call Transcript
Revenue
$38.51M
▲ 83.5% YoY
Diluted EPS
$-0.35
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Adaptive Biotechnologies Corp (ADPT) Q1 2021 Earnings Call Transcript
Revenue
$38.44M
▲ 83.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Adaptive Biotechnologies Corp (ADPT) Q4 2020 Earnings Call Transcript
Revenue
$30.18M*
▲ 24.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-10
Adaptive Biotechnologies Corp (ADPT) Q3 2020 Earnings Call Transcript
Revenue
$26.30M
▲ 0.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Adaptive Biotechnologies Corp (ADPT) Q2 2020 Earnings Call Transcript
Revenue
$20.99M
▼ 5.2% YoY
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-12
Adaptive Biotechnologies Corp (ADPT) Q1 2020 Earnings Call Transcript
Revenue
$20.91M
▲ 65.1% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–27 of 27 webcasts
Key facts CIK 1478320 CUSIP 00650F109 13F (30d) 8 filings 8 filers Visit website Investor relations